Search PubMedSearch

PubMed · 1085585

[Thyrotropia].

Abstract

The significance of the radioimmunological dosage of the thyrotropic hormone (TSH) is examined as regards accordance between the experimental measure and the real behaviour of the hormone; as a matter of fact, in some particular conditions the problem of the specificity of dosage must be taken into account because of the possible interference of other hormones. From the clinical point of view the TSH radioimmuno assay is advisable for its accuracy, sensibility and specificity. On the other other hand, it is a lengthy and complex determination; instability of the labelled hormone is to be pointed out as the worst shortcoming. The procedures for clinical study of TSH are also examined with reference to an indirect evaluation of the thyroid function. tthe clinical application of TSH dosage in endrocrinology diagnostics, concerning both thyroid and hypophysis pathology, are discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Vigneri. 1975. [Thyrotropia].. https://pubmed.ncbi.nlm.nih.gov/1085585/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor.

One of the hallmarks of rheumatoid arthritis (RA) is the production of high titers of rheumatoid factor (RF) antibody directed against the Fc portion of IgG. Anti-Id that recognize the majority of monoclonal RF from patients with B cell dyscrasias are reactive with only 1 to 2% of these polyclonal RF from RA patients. We describe a new monoclonal anti-Id, 4C9, that recognizes a L chain determinant on polyclonal IgM RF from patients with RA but does not recognize a panel of monoclonal RF from patients with B cell malignancies. 4C9 reactivity is found in the serum of 34/43 RF-positive RA patients and in 12/12 RF-positive synovial fluids, but in only 1/14 RF-negative sera from RA patients and 1/22 sera containing monoclonal IgM RF. 4C9 reactivity is highly enriched in purified IgM RF from nine RA patients and represents a variable percentage of total IgM RF up to a maximum of 23%. Furthermore, 4C9 reactivity is enriched in the synovial fluid of three of five RA patients compared with serum, suggesting that 4C9-reactive IgM RF are synthesized within the joint. IgG RF from RA synovial fluids are not 4C9 reactive, indicating either that different genes are used to encode IgM and IgG RF in RA patients, or that IgG RF have somatically mutated away from idiotypic reactivity.

Antibodies, Anti-Idiotypic